Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorders With Chronic Hepatitis C Receiving Direct Acting Antiviral Treatment

NCT02648022 is registered in ClinicalTrials.gov with VA Office of Research and Development as lead sponsor.

NCT NCT02648022
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02648022 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Integrated Care for Patients With High Risk Substance Use and Psychiatric Disorders With Chronic Hepatitis C Receiving Direct Acting Antiviral Treatment
Lead sponsor
VA Office of Research and Development
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2012
Completion date
February 28, 2014
Enrollment
83 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression, fibrosis, hepatitis c, ptsd, substance use disorder